Adeodata R. Kekitiinwa

Kampala, C, Uganda

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Pathways of onward HIV disclosure in relationships among young people living with vertically acquired HIV receiving antiretroviral therapy: A qualitative analysis from the BREATHER Plus trial, South Africa.

Pathways of onward HIV disclosure in relationships among young people living with vertically acquired HIV receiving antiretroviral therapy: A qualitative analysis from the BREATHER Plus trial, South Africa.

Journal: Global public health

Published: August 20, 2026

Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV.

Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV.

Journal: Clinical pharmacology and therapeutics

Published: March 26, 2026

The role of parents and caregivers in motivating adolescents with HIV to participate in a long-acting injectable ART clinical trial in South Africa and Uganda.

The role of parents and caregivers in motivating adolescents with HIV to participate in a long-acting injectable ART clinical trial in South Africa and Uganda.

Journal: AIDS care

Published: February 26, 2026

Acceptability and feasibility of oral swabs for tuberculosis diagnosis in young children: a qualitative study from Uganda and Peru.

Acceptability and feasibility of oral swabs for tuberculosis diagnosis in young children: a qualitative study from Uganda and Peru.

Journal: Frontiers in tuberculosis

Published: February 25, 2026

Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

Journal: Open forum infectious diseases

Published: January 26, 2026

Efavirenz metabolism and CNS toxicity in Ugandan children: impact of CYP2B6 genotype and plasma metabolite profiles.

Efavirenz metabolism and CNS toxicity in Ugandan children: impact of CYP2B6 genotype and plasma metabolite profiles.

Journal: Frontiers in pharmacology

Published: December 30, 2025

PERFORMANCE OF FUJILAM VERSION 1 FOR THE DIAGNOSIS OF TUBERCULOSIS IN CHILDREN UNDER 5 YEARS IN UGANDA - A BRIEF REPORT.

PERFORMANCE OF FUJILAM VERSION 1 FOR THE DIAGNOSIS OF TUBERCULOSIS IN CHILDREN UNDER 5 YEARS IN UGANDA - A BRIEF REPORT.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Impact of integrating tuberculosis and orphans and vulnerable children services on case-finding and treatment outcomes.

Impact of integrating tuberculosis and orphans and vulnerable children services on case-finding and treatment outcomes.

Journal: AIDS (London, England)

Published: November 18, 2025

Integrating tuberculosis services with the Orphans and Vulnerable Children Program in Rwenzori region, Uganda, 2022-2023.

Integrating tuberculosis services with the Orphans and Vulnerable Children Program in Rwenzori region, Uganda, 2022-2023.

Journal: AIDS (London, England)

Published: November 18, 2025

Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.

Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 16, 2025

Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial.

Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 16, 2025

Longitudinal comparison of bone, growth, and biochemical markers in breastfed HIV-exposed uninfected and HIV-unexposed Ugandan children.

Longitudinal comparison of bone, growth, and biochemical markers in breastfed HIV-exposed uninfected and HIV-unexposed Ugandan children.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: September 19, 2025

Showing 1-12 of 102

Last Updated: 09/26/2026